| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Mazumdar Claire is a Chief Executive Officer at BCAX. Recent filings cover 0 purchases and 17 sales. Those positions are worth an estimated $10.1M at current prices.
Our model assigns Mazumdar Claire a middling insider score of 52/100, based on 9 past trades. On a 3-month view, 44.4% of the rated trades came out ahead, averaging -6.4% over three months.
Mazumdar Claire's largest disclosed position is in BCAX as Chief Executive Officer, worth about $10.1M. The recent filings there lean toward selling, a net 200,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 10,000 | $27.98 | $279,750.00 | -2.7% | - | - | |
| Jul 10, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 10,000 | $28.42 | $284,198.38 | -2.7% | -40.3% | - | |
| May 18, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $20.04 | $300,578.60 | -4.0% | +29.3% | - | |
| Apr 20, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $23.61 | $354,145.50 | -4.0% | +15.7% | - | |
| Mar 20, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $18.82 | $282,365.69 | -4.2% | +26.2% | - | |
| Mar 9, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 36,766 | $19.17 | $704,657.16 | -9.8% | +2.1% | - | |
| Mar 6, 2026 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 8,234 | $18.74 | $154,324.53 | -2.4% | +10.7% | - | |
| Nov 24, 2025 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 41,163 | $18.86 | $776,428.85 | -11.7% | -13.1% | - | |
| Oct 16, 2025 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 24,103 | $18.83 | $453,760.67 | -7.2% | -3.5% | -10.2% | |
| Oct 15, 2025 | BCAX Bicara Therapeutics Inc. | Chief Executive Officer | Sale+OE10b5-1 | 24,734 | $18.88 | $466,936.46 | -7.4% | -6.8% | -6.3% |